|
RVNC
|
Revance Therapeutics, Inc.
|
5.09%
|
US
|
NASDAQ
|
|
PRGO
|
Perrigo Company
|
4.91%
|
US
|
NYSE
|
|
OGN
|
Organon & Co.
|
4.73%
|
US
|
NYSE
|
|
VTRS
|
Viatris Inc.
|
4.67%
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
4.58%
|
US
|
NYSE
|
|
ELAN
|
Elanco Animal Health Incorporated
|
4.36%
|
US
|
NYSE
|
|
MRK
|
Merck & Company, Inc.
|
4.33%
|
US
|
NYSE
|
|
ZTS
|
Zoetis Inc.
|
4.28%
|
US
|
NYSE
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
4.27%
|
US
|
NASDAQ
|
|
JNJ
|
Johnson & Johnson
|
4.24%
|
US
|
NYSE
|
|
LLY
|
Eli Lilly and Company
|
4.15%
|
US
|
NYSE
|
|
RPRX
|
Royalty Pharma plc
|
4.00%
|
US
|
NASDAQ
|
|
PFE
|
Pfizer, Inc.
|
3.91%
|
US
|
NYSE
|
|
BMY
|
Bristol-Myers Squibb Company
|
3.86%
|
US
|
NYSE
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
3.61%
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
3.43%
|
US
|
NASDAQ
|
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
3.27%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
3.13%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
2.42%
|
US
|
NASDAQ
|
|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
1.74%
|
US
|
NASDAQ
|